Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Identification of Chlamydia pneumoniae candidate genes that interact with human apoptotic factor caspase-9.

Aziz MA, Ushirokita R, Azuma Y.

J Gen Appl Microbiol. 2018 May 15. doi: 10.2323/jgam.2017.12.008. [Epub ahead of print]

2.

Linking Antimicrobial Potential of Natural Products Derived from Aquatic Organisms and Microbes Involved in Alzheimer's Disease - A Review.

Stojkovic D, Kostic M, Smiljkovic M, Aleksic M, Vasiljevic P, Nikolic M, Sokovic M.

Curr Med Chem. 2018 Mar 8. doi: 10.2174/0929867325666180309103645. [Epub ahead of print]

PMID:
29521212
3.

Infectious Agents and Neurodegenerative Diseases: Exploring the Links.

Alam MZ, Alam Q, Kamal MA, Jiman-Fatani AA, Azhar EI, Khan MA, Haque A.

Curr Top Med Chem. 2017;17(12):1390-1399. doi: 10.2174/1568026617666170103164040. Review.

PMID:
28049398
4.

Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation.

Miklossy J, McGeer PL.

Aging (Albany NY). 2016 Apr;8(4):575-88. doi: 10.18632/aging.100921. Review.

5.

[Alzheimer's disease: the infectious hypothesis].

Roubaud Baudron C, Varon C, Mégraud F, Salles N.

Geriatr Psychol Neuropsychiatr Vieil. 2015 Dec;13(4):418-24. doi: 10.1684/pnv.2015.0574. Review. French.

PMID:
26707559
6.

Comparative genomic analysis of human Chlamydia pneumoniae isolates from respiratory, brain and cardiac tissues.

Roulis E, Bachmann NL, Myers GS, Huston W, Summersgill J, Hudson A, Dreses-Werringloer U, Polkinghorne A, Timms P.

Genomics. 2015 Dec;106(6):373-83. doi: 10.1016/j.ygeno.2015.09.008. Epub 2015 Sep 28.

7.

Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.

Harris SA, Harris EA.

J Alzheimers Dis. 2015;48(2):319-53. doi: 10.3233/JAD-142853. Review.

8.

Infectious Burden and Cognitive Decline in the Northern Manhattan Study.

Wright CB, Gardener H, Dong C, Yoshita M, DeCarli C, Sacco RL, Stern Y, Elkind MS.

J Am Geriatr Soc. 2015 Aug;63(8):1540-5. doi: 10.1111/jgs.13557.

9.

Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease.

Lim C, Hammond CJ, Hingley ST, Balin BJ.

J Neuroinflammation. 2014 Dec 24;11:217. doi: 10.1186/s12974-014-0217-0.

10.

Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae.

Little CS, Joyce TA, Hammond CJ, Matta H, Cahn D, Appelt DM, Balin BJ.

Front Aging Neurosci. 2014 Dec 5;6:304. doi: 10.3389/fnagi.2014.00304. eCollection 2014.

11.

Bacterial infection and Alzheimer's disease: a meta-analysis.

Maheshwari P, Eslick GD.

J Alzheimers Dis. 2015;43(3):957-66. doi: 10.3233/JAD-140621.

PMID:
25182736
12.

A study on the association between infectious burden and Alzheimer's disease.

Bu XL, Yao XQ, Jiao SS, Zeng F, Liu YH, Xiang Y, Liang CR, Wang QH, Wang X, Cao HY, Yi X, Deng B, Liu CH, Xu J, Zhang LL, Gao CY, Xu ZQ, Zhang M, Wang L, Tan XL, Xu X, Zhou HD, Wang YJ.

Eur J Neurol. 2015 Dec;22(12):1519-25. doi: 10.1111/ene.12477. Epub 2014 Jun 9.

PMID:
24910016
13.

[Chlamydial infection of the central nervous system. Laboratory diagnosis and clinic and morphological features].

Vaĭnshenker IuI, Nuralova IV, Onishenko LS.

Arkh Patol. 2014 Jan-Feb;76(1):57-62. Review. Russian.

PMID:
24745195
14.

Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Huston WM, Barker CJ, Chacko A, Timms P.

J Bacteriol. 2014 Jun;196(11):1915-24. doi: 10.1128/JB.01476-14. Epub 2014 Mar 28. Review.

15.

Infections caused by Chlamydophila pneumoniae.

Choroszy-Król I, Frej-Mądrzak M, Hober M, Sarowska J, Jama-Kmiecik A.

Adv Clin Exp Med. 2014 Jan-Feb;23(1):123-6. Review.

16.

In silico synteny based comparative genomics approach for identification and characterization of novel therapeutic targets in Chlamydophila pneumoniae.

Ravindranath BS, Krishnamurthy V, Krishna V, C SK.

Bioinformation. 2013 Jun 8;9(10):506-10. doi: 10.6026/97320630009506. Print 2013.

17.

A paradigm shift for evaluating pharmacotherapy for Alzheimer's disease: the 10-patient screening protocol.

Weinstein JD, Gonzalez ER, Egleton RD, Hunt DA.

Consult Pharm. 2013 Jul;28(7):443-54. doi: 10.4140/TCP.n.2013.443. Review.

PMID:
23835462
18.

Infectious agents and neurodegeneration.

De Chiara G, Marcocci ME, Sgarbanti R, Civitelli L, Ripoli C, Piacentini R, Garaci E, Grassi C, Palamara AT.

Mol Neurobiol. 2012 Dec;46(3):614-38. doi: 10.1007/s12035-012-8320-7. Epub 2012 Aug 17. Review.

19.

Recent publications in medical microbiology and immunology: a retrospective.

Doerr HW, Cinatl J.

Med Microbiol Immunol. 2012 Feb;201(1):1-5. doi: 10.1007/s00430-011-0219-9. Epub 2011 Oct 29. Review.

PMID:
22033658
20.

Chlamydia pneumoniae inhibits activated human T lymphocyte proliferation by the induction of apoptotic and pyroptotic pathways.

Olivares-Zavaleta N, Carmody A, Messer R, Whitmire WM, Caldwell HD.

J Immunol. 2011 Jun 15;186(12):7120-6. doi: 10.4049/jimmunol.1100393. Epub 2011 May 4.

Supplemental Content

Loading ...
Support Center